GA2LEN NoE calls for more focus on allergies in FP7

The Network of Excellence (NoE) GA2LEN is urging policy makers to support the European Parliament's proposal to include allergic diseases in the health priorities of the Seventh Framework Programme (FP7).

While allergies are mentioned among the food research priorities in the European Commission's proposal, members of GA2LEN would like to see the wider allergy problem a top priority for health research. Only 8% of allergies in Europe are related to food.

"The absence of the wider allergy problem as a top concern in health research agenda threatens to compromise overall progress in the understanding of this complex condition," says the Network in a statement.

Allergies are a global problem, although the presentation and cause of the reactions vary. Researchers believe that the many different aspects of the condition, as well as its triggers, must be addressed if we are to gain a comprehensive understanding of allergic diseases as a whole.

Allergies can be fatal. According to the World Health Organization (WHO), asthma kills someone in Europe every hour. And the problem is becoming more widespread -one child in three is now allergic to something, and by 2015, half of all Europeans may be suffering from one or more allergic condition.

For sufferers, allergies can have a major impact of daily life. Children with allergic diseases miss days at school and must sometimes abstain from sport and other recreational activities, while breathing and skin problems dent the confidence of children and adults.

GA2LEN also highlights the financial costs of allergies, which estimates suggest amount to €100 billion per year.

The GA2LEN network brings together 26 allergy research centres around Europe with the aim of advancing diagnosis, prevention and treatment of allergic diseases. In recent months, a European database of comparable, longitudinal epidemiological studies, known has cohorts, has been completed. This should help scientists to conduct a more reliable analysis of the multiple genetic and environmental factors causing allergies.

For further information on GA2LEN, please visit:
http://www.ga2len.net

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...